Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-Current DebtOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Other Working Capital Changes: 2021-2025

Historic Other Working Capital Changes for Legend Biotech (LEGN) over the last 3 years, with Jun 2025 value amounting to $298,000.

  • Legend Biotech's Other Working Capital Changes rose 257.67% to $298,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $239,000, marking a year-over-year increase of 313.39%. This contributed to the annual value of $3.7 million for FY2022, which is 411.57% up from last year.
  • Per Legend Biotech's latest filing, its Other Working Capital Changes stood at $298,000 for Q2 2025, which was down 37.00% from $473,000 recorded in Q1 2025.
  • In the past 5 years, Legend Biotech's Other Working Capital Changes registered a high of $2.8 million during Q4 2022, and its lowest value of -$902,000 during Q2 2021.
  • Over the past 3 years, Legend Biotech's median Other Working Capital Changes value was $77,000 (recorded in 2024), while the average stood at $45,143.
  • As far as peak fluctuations go, Legend Biotech's Other Working Capital Changes surged by 2,540.00% in 2022, and later tumbled by 313.57% in 2023.
  • Legend Biotech's Other Working Capital Changes (Quarterly) stood at -$575,000 in 2021, then spiked by 581.04% to $2.8 million in 2022, then crashed by 313.57% to -$425,000 in 2023, then spiked by 55.53% to -$343,000 in 2024, then soared by 257.67% to $298,000 in 2025.
  • Its Other Working Capital Changes stands at $298,000 for Q2 2025, versus $473,000 for Q1 2025 and -$343,000 for Q3 2024.